Identifying brain complications in critically ill patients
Bio-digital Rapid Alert to Identify Neuromorbidity
This study is looking at how to spot hidden brain problems in seriously ill patients, especially those in intensive care, so we can help them recover better and faster, particularly for those with conditions like COVID-19.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10929303 on NIH RePORTER |
What this research studies
This research investigates the silent development of neurologic complications, known as neuromorbidity, in critically ill patients, particularly those in intensive care units. It focuses on patients with primary neurologic conditions and those at risk due to underlying diseases, such as COVID-19. The study aims to identify these complications early, as they can arise from various factors including physiological instability and medication side effects. By utilizing advanced monitoring techniques, the research seeks to improve the detection and management of these complications to enhance patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include critically ill patients, particularly those admitted to intensive care units with neurologic conditions or those at risk for developing neuromorbidity.
Not a fit: Patients who are not critically ill or do not have underlying conditions that predispose them to neuromorbidity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and better management of neurologic complications in critically ill patients, potentially improving recovery and quality of life.
How similar studies have performed: Previous research has indicated that early detection of neurologic complications in critically ill patients can lead to improved outcomes, suggesting that this approach has potential for success.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Clark, Robert S B — University of Pittsburgh at Pittsburgh
- Study coordinator: Clark, Robert S B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.